About MedTech Acquisition Corporation
MedTech Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York. Address: 600 Fifth Avenue, New York, NY, United States, 10022
MedTech Acquisition Corporation News and around…
Latest news about MedTech Acquisition Corporation (MTACU) common stock and company :
Memic Innovative Surgery will no longer go public through a $1 billion merger with MedTech Acquisition Corp. The companies agreed to terminate the merger announced last August, according to a joint statement. “While we are disappointed that our proposed business combination with Memic will not be consummated, we believe that Memic’s Hominis system and its innovative technology, as well as Memic’s highly accomplished management team, will position Memic for future success,” said MedTech CEO Christopher Dewey. Memic, headquartered in Fort Lauderdale and Israel, is the maker of the first U.S. Food and Drug Administration-approved surgical robot authorized to perform transvaginal gynecological procedures, including benign hysterectomy.
TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, and Memic Innovative Surgery Ltd. (“Memic”), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that both companies have mutually agreed to terminate, effective immediately, their previously anno
In trading on Tuesday, shares of Medtech Acquisition Corporation - Unit (MTACU) crossed above their 200 day moving average of $10.13, changing hands as high as $10.15 per share. Medtech Acquisition Corporation - Unit shares are currently trading up about 1.4% on the day..
Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that HCA Florida Healthcare's Kendall Regional Medical Center, AdventHealth Celebration and The Women's Hospital at Jackson Memorial have acquired the Hominis® Surgical System for use in single site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures including benign hysterectomy. Hominis is the first a
2021 was a whirlwind year for South Florida's technology sector as out-of-state businesses migrated to the area and local companies attracted more funding than ever. It was also a big year for mergers and acquisitions. Here's a look at 19 tri-county firms that entered mergers or acquisitions in 2021.
If you want to know who really controls MedTech Acquisition Corporation ( NASDAQ:MTAC ), then you'll have to look at...
Memic Innovative Surgery Ltd. (the "Company" or "Memic"), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that Robert L. Ryan and Sandra Morgan have agreed to join the company's board of directors. Ryan and Morgan, who served in leadership roles at companies including Medtronic and HCA, respectively, will join the board pending the closing of the business combination agreement between Memic and MedTech Acquisition Corpo
NEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: First Reserve Sustainable Growth Corp. (NASDAQ: FRSG) FRSG has agreed to merge with EO Charging
Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acquisition Corporation (NASDAQ: MTAC), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, including surgical robots.
BALA CYNWYD, PA / ACCESSWIRE / August 13, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of MedTech Acquisition Corporation ("MedTech" or the "Company") (Nasdaq:MTAC) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which MedTech, a special purpose acquisition company, will combine withMemic Innovative Surgery Ltd. ("Memic"), a medical de
Memic Innovative Surgery Ltd. (the "Company" or "Memic"), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, and MedTech Acquisition Corporation (Nasdaq: MTAC) ("MedTech"), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, including surgical robotics, today announced that they have entered into a definitive agreement for a business combination. Upon the closing of the transaction, the combined com
New York, NY, June 02, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTACU) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq’s continued listing requirements